Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

Pharmacodynamic profile in East Asian patients with ACS treated with prasugrel standard-dose v de-escalation strategy: a randomized A-MATCH trial

(2021) Young-Hoon Jeong et al.   THROMBOSIS AND HAEMOSTASIS

1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation

(2021) Sung-Jin Hong et al.   JACC-Cardiovascular Interventions

De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes

(2021) Satoshi Shoji et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bleeding avoidance strategies in percutaneous coronary intervention

(2021) Davide Capodanno et al.   Nature Reviews Cardiology

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

(2021) Marco Valgimigli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis

(2021) Raffaele Piccolo et al.   EuroIntervention

Bayesian Analysis Reporting Guidelines

(2021) John K. Kruschke   Nature Human Behaviour

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial

(2021) Chan Joon Kim et al.   LANCET

Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome

(2020) Byeong-Keuk Kim et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2020) Jean-Philippe Collet et al.   EUROPEAN HEART JOURNAL

Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS

(2020) Usman Baber et al.   EUROPEAN HEART JOURNAL

Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI

(2020) Davide Capodanno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial

(2020) Hyo-Soo Kim et al.   LANCET

Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey

(2020) Davide Cao et al.   EUROPEAN HEART JOURNAL

Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Insights From a Network Meta-Analysis of Randomized Trials

(2020) Toshiki Kuno et al.   Cardiovascular Revascularization Medicine

Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention

(2019) Joo-Yong Hahn et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI

(2019) Daniel M.F. Claassens et al.   NEW ENGLAND JOURNAL OF MEDICINE

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes

(2019) Mariusz Tomaniak et al.   JAMA Cardiology

6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

(2018) Joo-Yong Hahn et al.   LANCET

Switching from ticagrelor to clopidogrel in patients with ST-segment elevation myocardial infarction undergoing successful percutaneous coronary intervention in real-world China:Occurrence, reasons and long-term clinical outcomes

(2018) Xin-yun Li et al.   CLINICAL CARDIOLOGY

ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy

(2018) Davide Capodanno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial

(2018) Elvin Kedhi et al.   BMJ-British Medical Journal

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study

(2017) Thomas Cuisset et al.   EUROPEAN HEART JOURNAL

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin

(2017) Romain Didier et al.   JACC-Cardiovascular Interventions

Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation

(2017) Masato Nakamura et al.   JACC-Cardiovascular Interventions

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

(2017) Dirk Sibbing et al.   LANCET

Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent

(2016) Yaling Han et al.   Circulation-Cardiovascular Interventions

Network meta-analysis: an introduction for clinicians

(2016) Benjamin Rouse et al.   Internal and Emergency Medicine

6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation

(2016) Sung-Jin Hong et al.   JACC-Cardiovascular Interventions

Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial

(2016) Guillaume Cayla et al.   LANCET

Six Versus Twelve Months Clopidogrel Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup Analysis

(2016) Raphaela Lohaus et al.   Scientific Reports

A New Strategy for Discontinuation of Dual Antiplatelet Therapy

(2012) Byeong-Keuk Kim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents

(2011) Hyeon-Cheol Gwon et al.   CIRCULATION

A Prospective Natural-History Study of Coronary Atherosclerosis

(2011) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

(2010) Georgia Salanti et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY